Juvenile Dermatomyositis
- 11 February 2011
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 13 (3) , 216-224
Abstract
Juvenile dermatomyositis (JDM) is a rare, often chronic autoimmune disease with onset during childhood. It is characterized by weakness in proximal muscles and pathognomonic skin rashes. Although the etiology remains unclear, it has been proposed that JDM is caused by a vasculopathy within the muscle tissue and multiple other organ systems of genetically susceptible individuals, possibly in response to environmental triggers. The goals of treatment include control of the underlying inflammatory myositis and prevention and/or treatment of complications (eg, contractures and calcinosis). Delayed treatment may lead to poorer outcome in terms of disease course and calcinosis. The course in JDM is variable. Monocyclic disease occurs in about one third of patients. These patients have a good response to standard therapy. Early recognition and aggressive immunosuppressive treatment result in improved prognosis.Keywords
This publication has 55 references indexed in Scilit:
- Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositisArthritis Care & Research, 2010
- Dermatomyositis and Type 1 InterferonsCurrent Rheumatology Reports, 2010
- Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathiesArthritis Care & Research, 2010
- Protocols for the initial treatment of moderately severe juvenile dermatomyositis: Results of a Children's Arthritis and Rheumatology Research Alliance Consensus ConferenceArthritis Care & Research, 2010
- Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage indexArthritis & Rheumatism, 2009
- Elevated serum interferon‐α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty‐six months of therapyArthritis & Rheumatism, 2009
- The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: A propensity score analysisArthritis Care & Research, 2008
- Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositisArthritis Care & Research, 2008
- Immunogenetic risk and protective factors for juvenile dermatomyositis in CaucasiansArthritis & Rheumatism, 2006
- Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcificationThe Journal of Pediatrics, 1983